Metagenomi Therapeutics, Inc.

Regulation FD Disclosure

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G)

General form for quarterly reports under Section 13 or 15(d)

Results of Operations and Financial Condition

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

General form for quarterly reports under Section 13 or 15(d)

Results of Operations and Financial Condition

Annual Report Scanned (Paper)

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Annual report pursuant to Section 13 or 15(d)

Results of Operations and Financial Condition

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year

General form for quarterly reports under Section 13 or 15(d)

Results of Operations and Financial Condition

Entry into a Material Definitive Agreement

General form for quarterly reports under Section 13 or 15(d)

Results of Operations and Financial Condition

Submission of Matters to a Vote of Security Holders

Other Events

General form for quarterly reports under Section 13 or 15(d)

Results of Operations and Financial Condition

Annual Report Scanned (Paper)

Definitive Proxy Statement

Additional Information for Proxy Statement/ Votes

Notice of Effectiveness

Correspondence with the SEC

Letter from the SEC

Annual report pursuant to Section 13 or 15(d)

Results of Operations and Financial Condition

Entry into a Material Definitive Agreement

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Registration statement under Securities Act of 1933

5.02,7.01,9.01

Other Events

General form for quarterly reports under Section 13 or 15(d)

2.02,9.01

8.01,9.01

General form for quarterly reports under Section 13 or 15(d)

2.02,9.01

General form for quarterly reports under Section 13 or 15(d)

2.02,7.01,9.01

Annual report pursuant to Section 13 or 15(d)

Prospectus Supplement with Pricing Information

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

No description available

Notice of Effectiveness

Certification of approval for listing and registration on a national securities exchange

Correspondence with the SEC

Amended Initial Registration Statement

Letter from the SEC

Correspondence with the SEC

Correspondence with the SEC

Correspondence with the SEC

Registration of Securities on Exchange

Amended Initial Registration Statement

Correspondence with the SEC

Correspondence with the SEC

Amended Initial Registration Statement

Correspondence with the SEC

Registration (IPO) statement under Securities Act of 1933

Letter from the SEC

Draft registration statement (confidential submission) (amendment)

No description available

No description available

Draft registration statement (confidential submission) (amendment)

Letter from the SEC

Draft registration statement (confidential submission)

06b

06b

06b

06b

06b

Reid Laurence

Wapnick Pamela

Irish Jian

Wein Matthew

Eckhardt Juergen

BJERKHOLT ERIC

Dere Willard H

Reid Laurence

Irish Jian

Wapnick Pamela

Wein Matthew

Wein Matthew

Wapnick Pamela

Irish Jian

Wapnick Pamela

Wein Matthew

Irish Jian

Wein Matthew

Wapnick Pamela